China Nuvo Solar Energy, Inc. CNUV
We are presenting CNUV as a momentum play this morning. On Wednesday, the stock traded over eleven times its 3mo avg. volume.
We cannot confirm the validity the following assertion, however, rumor has it that CNUV has a series of press releases planned, so we are going to leave the stock on our radar to see how the situation plays out.
The first of these releases went out this morning:
WEST PALM BEACH, Fla., Nov. 3, 2011 /PRNewswire via COMTEX/ — China Nuvo Solar Energy, Inc. (OTCQB: CNUV) today announced that it has signed a Non-Binding Letter of Intent (“LOI”) to acquire a distributor of surgical implants. Pursuant to the terms of the LOI, the Company has contemplated that upon the anticipated closing of the transaction that the target distribution company would become a new wholly owned subsidiary of CNUV.
Exit Only, Inc. EXTO
We are still bullish on EXTO. Yesterday the stock continued to achieve higher highs and higher lows; currently the MACD is converging toward an imminent cross, which will only serve to increase our bullish sentiment.
Mistral Ventures Inc MILV
Another stock with anticipatory news out yesterday is MILV. It was basically an allusion to another development that should be occurring within the next week.
In the meantime, MILV has provided traders with continual opportunity. Yesterday saw a high of .10, a gain of 82% from our first alert at .055.
As with RAYS, MILV has enjoyed a long period of positive flow, so an argument can be made for taking profits. At the very least, one should remain vigilant as the stock is beginning to appear slightly overbought.
CAPE CORAL, Fla., Nov. 2, 2011 /PRNewswire via COMTEX/ — Nature’s Bioceuticals, a wholly owned subsidiary of Mistral Ventures Inc. (MILV.pk – News) announced that it has reached an agreement in principal with the inventor of a formula that could have life changing results for hundreds of millions of people worldwide afflicted with the disease. It is expected that the formal agreement will be executed in the coming week, at which point details of the product will be released.
Incoming search terms:
- Robert DeZanger